Novel Biomarkers for Risk Stratification in NSTE-ACS: Is There a Place for Cathepsin S?

Antoniades C., Polkinghorne MD.

DOI

10.1016/j.jacc.2022.06.023

Type

Journal article

Journal

J Am Coll Cardiol

Publication Date

06/09/2022

Volume

80

Pages

1011 - 1013

Keywords

GRACE, NSTE-ACS, cathepsin S, reclassification, residual risk, risk stratification, Acute Coronary Syndrome, Biomarkers, Cathepsins, Humans, Risk Assessment

Permalink Original publication